Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingcong Wang

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
International Journal of Oncology|June 15, 2018
Dihydrocelastrol exerts potent antitumor activity in mantle cell lymphoma cells via dual inhibition of mTORC1 and mTORC2Yongsheng Xie, Bo Li, Wenxuan Bu, et al.
Cancer Letters|February 12, 2018
Dual inhibition of mTORC1/2 by DCZ0358 induces cytotoxicity in multiple myeloma and overcomes the protective effect of the bone marrow microenvironmentLu Gao, Bo Li, Guang Yang, et al.
Cancer Letters|December 25, 2018
Rafoxanide, an organohalogen drug, triggers apoptosis and cell cycle arrest in multiple myeloma by enhancing DNA damage responses and suppressing the p38 MAPK pathwayWenqin Xiao, Zhijian Xu, Shuaikang Chang, et al.
Acta Biochimica Et Biophysica Sinica|July 3, 2018
Targeting the PI3K/Akt/mTOR signaling pathway by pterostilbene attenuates mantle cell lymphoma progressionDandan Yu, Yong Zhang, Gege Chen, et al.
Cancer Letters|March 13, 2020
A novel phosphoramide compound, DCZ0847, displays in vitro and in vivo anti-myeloma activity, alone or in combination with bortezomibGege Chen, Ke Hu, Haiguo Sun, et al.
Signal Transduction and Targeted Therapy|April 17, 2020
A novel silicone derivative of natural osalmid (DCZ0858) induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma via the JAK2/STAT3 pathwayKang Lu, Bo Li, Hui Zhang, et al.
Cell Death & Disease|July 2, 2025
KDM4B enhances immune surveillance via demethylating cGASQiao Peng, Huimin Zhuo, Minkang Wu, et al.
Acta Biochimica Et Biophysica Sinica|March 14, 2018
PKC inhibition of sotrastaurin has antitumor activity in diffuse large B-cell lymphoma via regulating the expression of MCT-1Gaomei Chang, Jiayi Zheng, Wenqin Xiao, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 11, 2020
A novel M phase blocker, DCZ3301 enhances the sensitivity of bortezomib in resistant multiple myeloma through DNA damage and mitotic catastropheLiangning Hu, Bo Li, Gege Chen, et al.
Journal of Biomedical Science|May 13, 2022
Preclinical validation and phase I trial of 4-hydroxysalicylanilide, targeting ribonucleotide reductase mediated dNTP synthesis in multiple myelomaYongsheng Xie, Yingcong Wang, Zhijian Xu, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
International Journal of Oncology|June 15, 2018
Dihydrocelastrol exerts potent antitumor activity in mantle cell lymphoma cells via dual inhibition of mTORC1 and mTORC2Yongsheng Xie, Bo Li, Wenxuan Bu, et al.
Cancer Letters|February 12, 2018
Dual inhibition of mTORC1/2 by DCZ0358 induces cytotoxicity in multiple myeloma and overcomes the protective effect of the bone marrow microenvironmentLu Gao, Bo Li, Guang Yang, et al.
Cancer Letters|December 25, 2018
Rafoxanide, an organohalogen drug, triggers apoptosis and cell cycle arrest in multiple myeloma by enhancing DNA damage responses and suppressing the p38 MAPK pathwayWenqin Xiao, Zhijian Xu, Shuaikang Chang, et al.
Acta Biochimica Et Biophysica Sinica|July 3, 2018
Targeting the PI3K/Akt/mTOR signaling pathway by pterostilbene attenuates mantle cell lymphoma progressionDandan Yu, Yong Zhang, Gege Chen, et al.
Cancer Letters|March 13, 2020
A novel phosphoramide compound, DCZ0847, displays in vitro and in vivo anti-myeloma activity, alone or in combination with bortezomibGege Chen, Ke Hu, Haiguo Sun, et al.
Signal Transduction and Targeted Therapy|April 17, 2020
A novel silicone derivative of natural osalmid (DCZ0858) induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma via the JAK2/STAT3 pathwayKang Lu, Bo Li, Hui Zhang, et al.
Cell Death & Disease|July 2, 2025
KDM4B enhances immune surveillance via demethylating cGASQiao Peng, Huimin Zhuo, Minkang Wu, et al.
Acta Biochimica Et Biophysica Sinica|March 14, 2018
PKC inhibition of sotrastaurin has antitumor activity in diffuse large B-cell lymphoma via regulating the expression of MCT-1Gaomei Chang, Jiayi Zheng, Wenqin Xiao, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 11, 2020
A novel M phase blocker, DCZ3301 enhances the sensitivity of bortezomib in resistant multiple myeloma through DNA damage and mitotic catastropheLiangning Hu, Bo Li, Gege Chen, et al.
Journal of Biomedical Science|May 13, 2022
Preclinical validation and phase I trial of 4-hydroxysalicylanilide, targeting ribonucleotide reductase mediated dNTP synthesis in multiple myelomaYongsheng Xie, Yingcong Wang, Zhijian Xu, et al.
Pageof 4